Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development

Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development (Nasdaq)

UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that characterization work has demonstrated the ability to isolate ∆9-tetrahydrocannabinol (“THC”) and suppress background substrates effectively. Cannabix is developing an innovative FAIMS (field asymmetric waveform ion mobility spectrometry) based instrument for the detection of THC.

Using the gold standard of mass spectrometry in tandem with the Cannabix FAIMS prototype device, Graph A and B show suppression of background matrix allowing the THC peak to be easily recognized. This demonstrates the capability of the FAIMS device to isolate and detect THC from complex background matrix. The characterization work has been conducted using a bench version of the FAIMS device. Cannabix scientists have been actively tuning the FAIMS device coupled to real time switchable mass spectrometry to detect key molecules and their complex pathways in the body to enable the identification of recency of use.

Learn more about Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development.

X